IDENTIFICATION OF FASNALL, A NOVEL FASN INHIBITOR THAT ATTENUATES HIV-1 REPLICATION
HIV-1 engages host machinery to produce progeny, and thereby imposes a substantial burden to cellular metabolism. Thus, metabolic disorders, including body fat redistribution, often occur in people living with HIV-1. Many FA and lipid-biosynthesis enzymes use purine cofactors like ATP and NAPDH. We performed a functional proteomics screen to define how HIV-1 infection regulates purine-binding…